PepGen Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 30 Jun 2026
Net Income -$71.9MTTM through 30 Jun 2026
Free Cash Flow -$69.5MTTM through 30 Jun 2026
Margins
| Current |
|---|
Returns
-13.3%ROE
-11.4%ROA
Balance Sheet Health
Current Ratio13.36x
Cash & Equivalents$22.8M
Quality Metrics
Altman Z-Score0.90
Piotroski F-Score2 / 9
Earnings-Beat Rate100.0%
Multi-Year Trend
Diluted EPS-$1.00TTMFY2025: $-2.12
Dividend
No dividend
Capital Allocation
R&D Spend$52.8M
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.